PC
MTEM

PA Capital’s Molecular Templates, Inc. MTEM Stock Holding History

PA Capital’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-905
Closed -$89K – 153
2019
Q3 		$89K Buy
905
+146
+19% +$13.6K 0.09% 117
2019
Q2 		$95K Sell
759
-362
-32% -$39.3K 0.09% 103
2019
Q1 		$98K Buy
+1,121
New +$82.2K 0.09% 109

Other funds holding MTEM

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

PA Capital's MTEM Position: Q4 2019 in Review

PA Capital sold out of Molecular Templates, Inc. (MTEM) in Q4 2019, closing a stake of 905 shares — an estimated $89K sold.

PA Capital first reported a position in MTEM in Q1 2019 and held it in 3 quarters. The position peaked at $98K in Q1 2019. 87 funds tracked by Wall St. Rank hold MTEM as of Q4 2019.

  • PA Capital reported no remaining Molecular Templates, Inc. position as of Q4 2019 after selling out during the quarter.
  • PA Capital sold 905 Molecular Templates, Inc. shares in Q4 2019, an estimated $89K.
  • PA Capital first reported a position in Molecular Templates, Inc. in Q1 2019 and held it in 3 quarters.
  • PA Capital's Molecular Templates, Inc. position peaked at $98K in Q1 2019.
  • 87 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q4 2019.

Based on PA Capital's 13F filing for Q4 2019, filed 3 Feb 2020.